Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersOperating ExpensesOperating IncomeProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Pharma-Bio Serv (PBSV) Shares Outstanding (2016 - 2026)

Pharma-Bio Serv (PBSV) has disclosed Shares Outstanding for 13 consecutive years, with $23.5 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Shares Outstanding changed 0.0% year-over-year to $23.5 million, compared with a TTM value of $23.5 million through Oct 2025, changed 0.0%, and an annual FY2025 reading of $23.5 million, changed 0.0% over the prior year.
  • Shares Outstanding was $23.5 million for Q4 2025 at Pharma-Bio Serv, roughly flat from $23.5 million in the prior quarter.
  • Across five years, Shares Outstanding topped out at $23.5 million in Q1 2024 and bottomed at $23.4 million in Q1 2021.
  • Average Shares Outstanding over 5 years is $23.5 million, with a median of $23.5 million recorded in 2023.
  • The sharpest move saw Shares Outstanding increased 0.24% in 2023, then changed 0.0% in 2025.
  • Year by year, Shares Outstanding stood at $23.4 million in 2021, then rose by 0.1% to $23.5 million in 2022, then increased by 0.24% to $23.5 million in 2023, then rose by 0.03% to $23.5 million in 2024, then changed by 0.0% to $23.5 million in 2025.
  • Business Quant data shows Shares Outstanding for PBSV at $23.5 million in Q4 2025, $23.5 million in Q3 2025, and $23.5 million in Q2 2025.